Filing Details
- Accession Number:
- 0001209191-21-069313
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-13 17:53:51
- Reporting Period:
- 2021-12-10
- Accepted Time:
- 2021-12-13 17:53:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434316 | Fate Therapeutics Inc | FATE | Biological Products, (No Disgnostic Substances) (2836) | 651311552 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1854586 | Yu-Waye Chu | C/O Fate Therapeutics, Inc. 12278 Scripps Summit Drive San Diego CA 92131 | Senior Vp Clinical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-10 | 7,500 | $16.32 | 133,258 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-12-10 | 2,097 | $49.32 | 131,161 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-10 | 900 | $50.42 | 130,261 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-10 | 1,045 | $51.08 | 129,216 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-10 | 1,822 | $52.37 | 127,394 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-10 | 1,031 | $53.66 | 126,363 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-10 | 600 | $54.58 | 126,763 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-10 | 5 | $55.54 | 125,758 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-12-10 | 7,500 | $0.00 | 7,500 | $16.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 105,000 | 2029-04-15 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020.
- Represents the weighted average sale price of the shares sold ranging from $48.95 to $49.87 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 7.
- Represents the weighted average sale price of the shares sold ranging from $49.96 to $50.89 per share.
- Represents the weighted average sale price of the shares sold ranging from $50.96 to $51.22 per share.
- Represents the weighted average sale price of the shares sold ranging from $52.09 to $52.87 per share.
- Represents the weighted average sale price of the shares sold ranging from $53.10 to $54.02 per share.
- Represents the weighted average sale price of the shares sold ranging from $54.33 to $54.98 per share.
- The option shall vest as to 25% of the underlying shares on April 15, 2020 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date
Billionaire Hedge Funds
